Related Experiment Video
Updated: Oct 7, 2025

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
Published on: April 11, 2025
A Case of Paracentral Acute Middle Maculopathy Occurring After Pars Plana Vitrectomy
Gulsah Gumus1, Nese Alagoz2, Cengiz Alagoz2
1Department of Ophtalmology, Gaziantep Dr. Ersin Arslan Training and Research Hospital, Gaziantep, Turkey.
Abstract:
Paracentral acute middle maculopathy (PAMM) is a clinical finding that is thought to be a result of ischemia in the middle and deep capillary plexus of the retina. It has been reported in the literature that PAMM may be associated with systemic and vascular risk factors. This report describes a case of PAMM that occurred following a pars plana vitrectomy.
Insights
Paracentral acute middle maculopathy (PAMM) is a retinal vascular condition. This case report details PAMM occurring after pars plana vitrectomy surgery.
Area of Science:
- Ophthalmology
- Retinal Vascular Diseases
- Macular Disorders
Background:
- Paracentral acute middle maculopathy (PAMM) is characterized by ischemia in the retinal middle and deep capillary plexuses.
- PAMM is often linked to systemic and vascular risk factors.
- The pathogenesis of PAMM is not fully understood.
Observation:
- This report presents a case of PAMM.
- The patient developed PAMM subsequent to a pars plana vitrectomy.
- This association is not previously well-documented.
Findings:
- The case highlights a potential complication of pars plana vitrectomy.
- It suggests that surgical procedures can precipitate retinal vascular events.
- Further investigation into surgical impacts on retinal circulation is warranted.
Implications:
- This case broadens the known associations of PAMM.
- It underscores the importance of considering iatrogenic causes for retinal ischemia.
- Ophthalmologists should be aware of this potential postoperative complication.
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

